Researchers from Yale provide evidence that glial cells, in particular Bergmann glia in the cerebellum, may contribute to disease pathogenesis in SCA1. Learn more about the implications of this study on our understanding of how SCA1 might be treated.
Check out the latest SCAsource article: Spotlight on Glia in Spinocerebellar Ataxia Type 1 - National Ataxia Foundation